Your browser doesn't support javascript.
loading
Novel compound C150 inhibits pancreatic cancer through induction of ER stress and proteosome assembly.
Wang, Tao; Chen, Ping; Weir, Scott; Baltezor, Michael; Schoenen, Frank J; Chen, Qi.
Affiliation
  • Wang T; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas, KS, United States.
  • Chen P; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas, KS, United States.
  • Weir S; Department of Cancer Biology, University of Kansas Medical Center, Kansas, KS, United States.
  • Baltezor M; Biotechnology Innovation and Optimization Center, University of Kansas, Lawrence, KS, United States.
  • Schoenen FJ; Higuchi Biosciences Center, University of Kansas, Lawrence, KS, United States.
  • Chen Q; Medicinal Chemistry Core Laboratory, Lead Development and Optimization Shared Resource, University of Kansas Cancer Center, Lawrence, KS, United States.
Front Oncol ; 12: 870473, 2022.
Article in En | MEDLINE | ID: mdl-36276125
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland